Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Evans

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Physics in Medicine and Biology|February 13, 2023
Stereotactic body radiation therapy (SBRT) following Yttrium-90 (<sup>90</sup>Y) selective internal radiation therapy (SIRT): a feasibility planning study using<sup>90</sup>Y delivered doseStephen F Mee, Daniel F Polan, Yuni K Dewaraja, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2023
Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?Theodore S Lawrence, Madhava P Aryal, Joseph R Evans, et al.
The Journal of Clinical Investigation|January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJose V Moyano, Joseph R Evans, Feng Chen, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMycJohn R Prensner, Wei Chen, Sumin Han, et al.
Oncology Letters|November 4, 2024
Role of epidural disease in local control of spinal metastases treated with stereotactic body radiation therapyJoseph R Linzey, Michael J Strong, Varun G Kathawate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate CancerShuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
PET/CT-Based Absorbed Dose Maps in <sup>90</sup>Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRIZhonglin Lu, Daniel F Polan, Lise Wei, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Physics in Medicine and Biology|February 13, 2023
Stereotactic body radiation therapy (SBRT) following Yttrium-90 (<sup>90</sup>Y) selective internal radiation therapy (SIRT): a feasibility planning study using<sup>90</sup>Y delivered doseStephen F Mee, Daniel F Polan, Yuni K Dewaraja, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2023
Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?Theodore S Lawrence, Madhava P Aryal, Joseph R Evans, et al.
The Journal of Clinical Investigation|January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJose V Moyano, Joseph R Evans, Feng Chen, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMycJohn R Prensner, Wei Chen, Sumin Han, et al.
Oncology Letters|November 4, 2024
Role of epidural disease in local control of spinal metastases treated with stereotactic body radiation therapyJoseph R Linzey, Michael J Strong, Varun G Kathawate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate CancerShuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
PET/CT-Based Absorbed Dose Maps in <sup>90</sup>Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRIZhonglin Lu, Daniel F Polan, Lise Wei, et al.
Pageof 4